Ποια είναι η τιμή για Oscotec Inc. (039200)

Η τιμή για Oscotec Inc. (039200) είναι $24.76

Ποια είναι η κεφαλαιοποίηση αγοράς για Oscotec Inc. (039200)

Η κεφαλαιοποίηση αγοράς για Oscotec Inc. (039200) είναι $947.10M

Oscotec Inc. (039200) Τιμή και Κεφαλαιοποίηση Αγοράς

Oscotec Inc. is a biopharmaceutical company specializing in the discovery and development of novel therapeutic drugs. Its primary focus lies in advancing a pipeline of investigational medicines, including a SYK inhibitor currently in Phase IIa clinical trials for the treatment of both rheumatoid arthritis and immune thrombocytopenia. Another key asset is an FLT3 inhibitor, undergoing Phase I clinical evaluation for acute myeloid leukemia. The company is also developing an EGFR double mutation inhibitor aimed at non-small cell lung cancer, and an Anti-Tau antibody in the preclinical stage for Alzheimer's disease. Beyond its pharmaceutical endeavors, Oscotec Inc. diversifies its offerings with a range of dental health products, such as bone graft materials like InduCera, BioCera-F, and SynCeraII, alongside membranes including LysoGide and CollaGuide. Additionally, it markets functional ingredients designed to address specific health concerns, such as OPB for osteoporosis, AIF for arthritis, SGA for enhancing bone growth, and PRF-K for periodontal conditions. Established in 1988, the company, originally known as Oscotec Co., Ltd, adopted its current name, Oscotec Inc., in June 1999. It is headquartered in Seongnam, South Korea.

Η τιμή για 039200	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$137,588 $947.10M	NVDA	$5.264T	+555,688.48%
$122,883 $947.10M	AAPL	$4.701T	+496,286.90%
$109,184 $947.10M	GOOG	$4.177T	+440,949.69%
$99,780.01 $947.10M	MSFT	$3.817T	+402,962.47%
$74,920.90 $947.10M	AMZN	$2.866T	+302,543.81%

Η τιμή για 039200

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$137,588 $947.10M